evolution of innovation

evolution of
innovation

TNS® Advanced+ Serum—the next
generation of age-defying skin

  • more benefits1
  • radical results
  • starting in just 2 weeks2

The science of
aging skin

Aging skin presents itself in a variety
of ways, including:

  • Coarse wrinkles
  • Fine lines
  • Sagging skin
  • Uneven tone and texture

At SkinMedica®, we get to the source of
aging skin—diminishing growth factors.
This allows us to more effectively address
the visible signs of aging.

A revolution in rejuvenation

  • Colorless
  • Fragrance-free
  • Lightweight,
    Matte finish

  • Smooths coarse wrinkles
    and fine lines2
  • Clinically proven to address
    sagging skin2
  • Visible results starting in
    just 2 weeks2
  • Progressive results
    measured over 24 weeks2

The advanced+ difference

Two powerful blends work together
for our most comprehensive results.

Chamber 1:

TNS®-MR

This advanced formula acts on multiple
levels to help get you to age-defying results.

  • Next-generation growth factor blend— supports healthy skin functions
  • Innovative peptide complex—
    nourishing support for your skin

Chamber 2:

Renessensce (RSC)
Advanced

Specifically designed to support the
results of the growth factor blend,
this highly active blend of botanicals,
marine extracts, and peptides includes:

  • French flax seed— supports repair functions
  • Spanish marine extract— supports skin's renewal processes
  • Green microalgae— supports collagen and elastin levels

In Clinical Studies2:

6 YEARS YOUNGER

A third-party, validated psychometric scale
revealed that patients felt they looked up to
6 years younger after 12 weeks.

APPEARANCE OF SAGGING SKIN

Significant improvements in the appearance of
sagging skin after 8 weeks.

PROGRESSIVE IMPROVEMENT

Subjects felt increasingly more satisfied with
continued use measured over 24 weeks.

Dramatic, Age-Defying Benefits

Visible improvements starting at week 2

2-week-before-new 2-week-after-new
  • +
  • Baseline
  • +
  • 2 weeks

Female, age 60, Fitzpatrick Skin Type II.
Unretouched photos, taken in standard lighting.
Individual results may vary.

Progressive Improvements at week 24

24-week-before-new 24-week-after-new
  • +
  • Baseline
  • +
  • 24 weeks

Female, age 68, Fitzpatrick Skin Type II.
Unretouched photos, taken in standard lighting.
Individual results may vary.

References: 1. As compared to TNS Essential Serum®. 2. Data on file at SkinMedica®.

CAUTION: Do not use Retinol Complex if you are pregnant, lactating, or planning to become pregnant. Mild redness, peeling, and irritation are expected when using this product. Use a sunscreen and limit sun exposure while using this product and for a week following discontinuation.

CAUTION: GlyPro products used together may cause irritation.

Sunburn alert: AHA/BHA Exfoliating Cleanser, AHA/BHA Cream, Rejuvenative Toner, and all GlyPro products contain an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using these products and for a week following discontinuation.

IMPORTANT! SUNSCREEN IS REQUIRED TO OPTIMIZE AND MAINTAIN THE RESULTS OF USING LYTERA® 2.0 PIGMENT CORRECTING SERUM.

Most SkinMedica® products are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA, and the statements here have not been evaluated by the FDA.

SkinMedica® TOTAL DEFENSE + REPAIR Broad Spectrum Sunscreens (SPF 34, SPF 34 Tinted, and SPF 50+) and Essential Defense Broad Spectrum Sunscreens (Everyday Clear SPF 47, Mineral Shield Tinted SPF 32, and Mineral Shield SPF 35) are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 352.

The PA rating system is used in Japan to classify UVA protection and is not an FDA requirement on sunscreens sold in the U.S.

SkinMedica® Purifying Foaming Wash is an over-the-counter drug product that is formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 333 Subpart D.

Not all products are available in Canada. Subject to change at any time without prior notice.